About Ellodi Pharmaceuticals
Ellodi Pharmaceuticals is a company based in Ewing Township (United States) founded in 2020.. Ellodi Pharmaceuticals offers products and services including APT-1011 and FLUTE 3 Study. Ellodi Pharmaceuticals operates in a competitive market with competitors including Phathom Pharmaceuticals, VectivBio, Guangzhou Zhiyi Pharmaceutics, Lumena Pharma and Kamui Pharma, among others.
- Headquarter Ewing Township, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ellodi Pharmaceuticals
Ellodi Pharmaceuticals offers a comprehensive portfolio of products and services, including APT-1011 and FLUTE 3 Study. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Novel treatment for Eosinophilic Esophagitis through clinical development
Research study evaluating therapies for Eosinophilic Esophagitis patients
Funding Insights of Ellodi Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Ellodi Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ellodi Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ellodi Pharmaceuticals Comparisons
Competitors of Ellodi Pharmaceuticals
Ellodi Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Phathom Pharmaceuticals, VectivBio, Guangzhou Zhiyi Pharmaceutics, Lumena Pharma and Kamui Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for gastrointestinal diseases are developed by Phathom Pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Transformative therapeutics for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Second-generation probiotics are developed for gastrointestinal disorders.
|
|
| domain | founded_year | HQ Location |
Passionately pursuing better treatments for adults and children with rare liver diseases.
|
|
| domain | founded_year | HQ Location |
Probiotic medicines for treating gastrointestinal diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ellodi Pharmaceuticals
Frequently Asked Questions about Ellodi Pharmaceuticals
When was Ellodi Pharmaceuticals founded?
Ellodi Pharmaceuticals was founded in 2020.
Where is Ellodi Pharmaceuticals located?
Ellodi Pharmaceuticals is headquartered in Ewing Township, United States. It is registered at Ewing Township, New Jersey, United States.
What does Ellodi Pharmaceuticals do?
Ellodi Pharmaceuticals was founded in 2020 and is based in Ewing Township, United States. Focus is placed on the pharmaceutical sector, specifically gastroenterology, where therapeutics for disorders like Eosinophilic Esophagitis are developed. Proprietary orally disintegrating tablets, including APT-1011 and Esomeprazole ODT, are offered to address gastrointestinal conditions and rare chronic allergic inflammatory diseases. Operations center on research and product innovation for these targeted health issues.
Who are the top competitors of Ellodi Pharmaceuticals?
Ellodi Pharmaceuticals's top competitors include Phathom Pharmaceuticals, VectivBio and Lumena Pharma.
What products or services does Ellodi Pharmaceuticals offer?
Ellodi Pharmaceuticals offers APT-1011 and FLUTE 3 Study.